FREEOX BIOTECH SLDescobrir i desenvolupar medicaments per reduir els efectes de l'estrès oxidatiu en l'organisme, especialment en el sistema neurològic i cardiovascular. Estem desenvolupant teràpies neuroprotectores per reduir el dany resultant de la isquèmia i, d'aquesta manera, millorar la recuperació dels pacients.
Estat de l'empresa i àrees de tecnologia profunda de l'empresa
Estat de l'empresa
Estat de l'empresa
Àrea DeepTech
Àrea DeepTech
Informació sobre la spin-off
Descripció de l'empresa
Freeox Biotech is an innovative company born to discover and develop medicines addressed to reduce the effects of the oxidative stress in the organism, and especially those related to the neurological and cardiovascular system.We are focus mainly in Stroke, a condition characterized by the interruption of blood flow to the brain which is a leading cause of death and disability worldwide.
Descripció del producte
Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients.Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke.Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.